Extraperitoneal laparoscopic retroperitoneal lymph node dissection after chemotherapy for nonseminomatous testicular germ-cell tumor: surgical and oncological outcomes
Extraperitoneal laparoscopic retroperitoneal lymph node dissection after chemotherapy for nonseminomatous testicular germ-cell tumor: surgical and oncological outcomes
复制标题
非精原性睾丸生殖细胞肿瘤化疗后腹膜外腹腔镜腹膜后淋巴结清扫术:手术和肿瘤学结果
DOI:
10.1007/s11255-012-0195-z
复制
发表时间:
2012
影响因子:
2
通讯作者:
A. Ito
中科院分区:
文献类型:
--
作者:
Y. Arai;Y. Kaiho;S. Yamada;H. Saito;K. Mitsuzuka;S. Yamashita;S. Namiki;H. Nakagawa;S. Ishidoya;A. Ito
PurposeTo assess the surgical and oncological outcomes of laparoscopic retroperitoneal lymph node dissection (RPLND) after chemotherapy.MethodsTwenty patients with metastatic nonseminomatous testicular germ-cell tumor underwent extraperitoneal laparoscopic RPLND after chemotherapy. The procedure was not indicated for patients with a pre-chemotherapy mass larger than 5 cm. Morbidity and oncological outcome were reviewed retrospectively. Surgical complications were graded according to the Clavien classification system.ResultsLaparoscopic RPLND was completed in all patients, and there was no conversion to open surgery. The median operating time was 223 min (range, 137–399 min). The median blood loss was 20 ml (range, 10–520 ml). There were no intraoperative complications. Postoperatively, 4 patients (20 %) had prolonged lymphorrhea (grade I) and 9 (45 %) had chyle leakage (grade I). Histological examination of the residual mass revealed necrosis in 16 (80 %) and the presence of teratoma with/without viable tumor in 4 (20 %). With a median follow-up of 45 months (range, 24–112), no patient has had disease recurrence. Normal antegrade ejaculation was preserved in all of the 14 patients studied.ConclusionsExtraperitoneal laparoscopic RPLND can be performed with acceptable morbidity and excellent cancer control in select patients. Surgeons should be aware of relatively high incidence of chyle leakage following this procedure.